Primary Hyperoxaluria Type 1 (PH1)
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to PH1.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Congresses
Primary Hyperoxaluria Type 1 (PH1)
International Pediatric Nephrology Association (IPNA) 2025
Primary Hyperoxaluria Type 1 (PH1)
American Society of Nephrology (ASN) 2024
Publications
Primary Hyperoxaluria Type 1 (PH1)
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children
Genetics in Medicine
Primary Hyperoxaluria Type 1 (PH1)
Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study
Frontiers in Medicine
Primary Hyperoxaluria Type 1 (PH1)
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial
Clinical Journal of the American Society of Nephrology
Primary Hyperoxaluria Type 1 (PH1)
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
New England Journal of Medicine
Primary Hyperoxaluria Type 1 (PH1)
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
eLife
